Current recommendations for revascularization of non-infarct-related artery in patients presenting with ST-segment elevation myocardial infarction and multivessel disease

被引:2
|
作者
Towashiraporn, Korakoth [1 ]
机构
[1] Mahidol Univ, Fac Med Siriraj Hosp, Her Majesty Cardiac Ctr, Bangkok, Thailand
来源
关键词
ST-segment elevation myocardial infarction; multivessel disease; complete revascularization; percutaneous coronary intervention; infarct-related artery; PERCUTANEOUS CORONARY INTERVENTION; LESION-ONLY REVASCULARIZATION; CARDIOGENIC-SHOCK; SCIENTIFIC STATEMENT; RANDOMIZED-TRIAL; CULPRIT LESION; MANAGEMENT; PLAQUE; STEMI; OUTCOMES;
D O I
10.3389/fcvm.2022.969060
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ST-segment elevation myocardial infarction (STEMI) is a leading cause of morbidity and mortality worldwide. Immediate reperfusion therapy of the infarct-related artery (IRA) is the mainstay of treatment, either via primary percutaneous coronary intervention (PPCI) or thrombolytic therapy when PPCI is not feasible. Several studies have reported the incidence of multivessel disease (MVD) to be about 50% of total STEMI cases. This means that after successful PPCI of the IRA, residual lesion(s) of the non-IRA may persist. Unlike the atherosclerotic plaque of stable coronary artery disease, the residual obstructive lesion of the non-IRA contains a significantly higher prevalence of vulnerable plaques. Since these lesions are a strong predictor of acute coronary syndrome, if left untreated they are a possible cause of future adverse cardiovascular events. Percutaneous coronary intervention (PCI) of the obstructive lesion of the non-IRA to achieve complete revascularization (CR) is therefore preferable. Several major randomized controlled trials (RCTs) and meta-analyses demonstrated the clinical benefits of the CR strategy in the setting of STEMI with MVD, not only for enhancing survival but also for reducing unplanned revascularization. The CR strategy is now supported by recently published clinical practice guidelines. Nevertheless, the benefit of revascularization must be weighed against the risks from additional procedures.
引用
收藏
页数:10
相关论文
共 50 条
  • [1] Non-infarct related artery revascularization in ST-segment elevation myocardial infarction patients with multivessel disease
    Cheema, Asim N.
    Mehta, Shamir R.
    Verma, Subodh
    Bagai, Akshay
    CURRENT OPINION IN CARDIOLOGY, 2017, 32 (05) : 600 - 607
  • [2] Benefit of Revascularization in Non-Infarct-Related Artery in Multivessel Disease Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
    Chen, Huang-Chung
    Tsai, Tzu-Hsien
    Fang, Hsiu-Yu
    Sun, Cheuk-Kwan
    Lin, Yu-Chun
    Leu, Steve
    Chung, Sheng-Ying
    Chai, Han-Tan
    Yang, Cheng-Hsu
    Hsien, Yuan-Kai
    Wu, Chiung-Jen
    Yip, Hon-Kan
    INTERNATIONAL HEART JOURNAL, 2010, 51 (05) : 319 - 324
  • [3] Timing and modality of complete revascularization in patients presenting with ST-segment elevation myocardial infarction and multivessel coronary artery disease
    Benatti, Giorgio
    Gragnano, Felice
    Vignali, Luigi
    Calabro, Paolo
    Gurgoglione, Filippo Luca
    Niccoli, Giampaolo
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2023, 380 : 6 - 11
  • [4] Comparison of infarct-related artery vs multivessel revascularization in ST-segment elevation myocardial infarction with multivessel disease: Analysis from Korea Acute Myocardial Infarction Registry
    Lee, Hye Won
    Hong, Taek Jong
    Yang, Mi Jin
    An, Sung Gyu
    Oh, Jun-Hyok
    Choi, Jung Hyun
    Lee, Han Cheol
    Cha, Kwang Soo
    Hong, Ju Young
    CARDIOLOGY JOURNAL, 2012, 19 (03) : 256 - 266
  • [5] Optional Revascularization Strategies for Patients with ST-Segment Elevation Myocardial Infarction and Multivessel Disease
    Zhong, Peng-Yu
    Sun, Bin
    Cao, Hai -Ping
    Wang, Wei
    Xiong, Ting-Lin
    REVIEWS IN CARDIOVASCULAR MEDICINE, 2024, 25 (06)
  • [6] PREDICTORS OF MULTIVESSEL CORONARY ARTERY DISEASE IN YOUNG PATIENTS PRESENTING WITH ST-SEGMENT ELEVATION MYOCARDIAL INFARCTION
    Mir, Ayaz
    Ullah, Syed Zia
    Muhammad, Atif Sher
    Farooq, Faiza
    Ammar, Ali
    Rehman, Javaid Ur
    Saghir, Tahir
    PAKISTAN HEART JOURNAL, 2021, 54 (03): : 268 - 272
  • [7] Revascularization strategies in patients with ST-segment elevation myocardial infarction and multivessel coronary artery disease: urgent or staged?
    Cubero-Gallego, Hector
    Romaguera, Rafael
    Ariza-Sole, Albert
    Gomez-Hospital, Joan Antoni
    Cequier, Angel
    CARDIOVASCULAR DIAGNOSIS AND THERAPY, 2017, 7 : S82 - S85
  • [8] Impact of Multivessel Revascularization on Health Status Outcomes in Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Coronary Artery Disease
    Jang, Jae-Sik
    Spertus, John A.
    Arnold, Suzanne V.
    Shafiq, Ali
    Grodzinsky, Anna
    Fendler, Timothy J.
    Salisbury, Adam C.
    Tang, Fengming
    McNulty, Edward J.
    Grantham, J. Aaron
    Cohen, David J.
    Amin, Amit P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 66 (19) : 2104 - 2113
  • [9] The Inhibition of Evolocumab on Non-Infarct-Related Artery Disease in Patients with ST-Elevation Myocardial Infarction
    Zhao, Qi
    Sun, Siyuan
    Zhou, Fanghui
    Yue, Jingkun
    Luo, Xing
    Qu, Xiufen
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2023, 16 : 2771 - 2781
  • [10] Optimal Strategy for Complete Revascularization in ST-Segment Elevation Myocardial Infarction and Multivessel Disease
    Ueyama, Hiroki A.
    Akita, Keitaro
    Kiyohara, Yuko
    Takagi, Hisato
    Briasoulis, Alexandros
    Wiley, Jose
    Bangalore, Sripal
    Mehran, Roxana
    Stone, Gregg W.
    Kuno, Toshiki
    Bhatt, Deepak L.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (01) : 19 - 38